Since depression serves as one of the core reasons for disability in the United States, therefore, a number of factors need to be taken into consideration before its treatment. Certain serotonin reuptake inhibitors such as citalopram, fluoxetine, fluvoxamine, paroxetine, and sertraline fall amongst the most widely consumed drugs for the treatment ofdepression in adults. It is vital to know that adult patients might not realize the improvements in their mental health until at least 2-4 weeks of the treatment while only 50-60% might actually consider themselves in the recovery phase.
Every patient has the capability to deal with drugs infused in their bodies in a different manner. For instance, dissimilarity in genes serves as one of the reasons why the process of drug absorption might be well in some people than others.
Our DNA metabolic screening panel which is consist of (CYP2D6i,CYP2C19+,CYP3A4,CYP3A5) can help care provider in eliminating guess work and provided urgent care to the patient instead of following trial and error approach.
Although genetic variability along with other notable clinical aspects are likely to influence the NAD effectiveness to a higher degree, Neuroactivedrugs comprising of antidepressants, antipsychotics, and anxioleptics still serve the purpose when it comes to mental rehabilitation for patients.